Virpax Pharmaceuticals Recaps Milestones and Highlights Product Portfolio | Business Wire

We added VRP324 which is an intranasally delivered cannabidiol (‘CBD’) formulation for the management of epilepsy in adults and children. Our Envelta™ … Read source